StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3017% above fair value
$9.00−0.08 (-0.88%)

Close on Nov 18, 2026Market cap $40.97MP/E –Yield –

Harvard Bioscience gross margin

Gross margin is gross profit as a percentage of revenue.

Harvard Bioscience's gross margin for the twelve months ending Jun 30, 2026 was 58.2%. For fiscal 2025 it was 57.7%, against 58.2% the year before. The highest annual figure on record is 58.9% in fiscal 2023.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202557.7%−0.5
FY2024Dec 31, 202458.2%−0.7
FY2023Dec 31, 202358.9%+5.2
FY2022Dec 31, 202253.7%−3.2
FY2021Dec 31, 202156.9%+0.0
FY2020Dec 31, 202056.8%+1.5
FY2019Dec 31, 201955.4%+3.1
FY2018Dec 31, 201852.3%+1.7
FY2017Dec 31, 201750.6%+4.3
FY2016Dec 31, 201646.3%+1.5
FY2015Dec 31, 201544.8%−0.6
FY2014Dec 31, 201445.4%+0.1
FY2013Dec 31, 201345.4%−1.7
FY2012Dec 31, 201247.1%+1.0
FY2011Dec 31, 201146.1%−1.8
FY2010Dec 31, 201047.9%−0.7
FY2009Dec 31, 200948.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202655.6%−0.8
Q1 FY2026Mar 31, 202659.0%+3.0
Q4 FY2025Dec 31, 202559.7%+2.7
Q3 FY2025Sep 30, 202558.4%+0.3
Q2 FY2025Jun 30, 202556.4%−0.8
Q1 FY2025Mar 31, 202556.0%−4.3
Q4 FY2024Dec 31, 202457.1%−0.9
Q3 FY2024Sep 30, 202458.1%+0.0
Q2 FY2024Jun 30, 202457.2%−0.7
Q1 FY2024Mar 31, 202460.3%−0.9
Q4 FY2023Dec 31, 202358.0%+2.3
Q3 FY2023Sep 30, 202358.1%+12.9
Q2 FY2023Jun 30, 202358.0%+1.0
Q1 FY2023Mar 31, 202361.2%+5.0
Q4 FY2022Dec 31, 202255.7%−3.5
Q3 FY2022Sep 30, 202245.2%−9.8
Q2 FY2022Jun 30, 202257.0%+1.0
Q1 FY2022Mar 31, 202256.2%−1.0
Q4 FY2021Dec 31, 202159.2%+2.0
Q3 FY2021Sep 30, 202155.0%−1.2
Q2 FY2021Jun 30, 202156.0%−3.4
Q1 FY2021Mar 31, 202157.2%+2.6
Q4 FY2020Dec 31, 202057.2%+1.5
Q3 FY2020Sep 30, 202056.1%+1.5
Q2 FY2020Jun 30, 202059.4%+5.5
Q1 FY2020Mar 31, 202054.6%−2.7
Q4 FY2019Dec 31, 201955.6%+0.3
Q3 FY2019Sep 30, 201954.6%−0.6
Q2 FY2019Jun 30, 201953.9%+5.2
Q1 FY2019Mar 31, 201957.3%+7.7
Q4 FY2018Dec 31, 201855.3%+4.4
Q3 FY2018Sep 30, 201855.2%+4.5
Q2 FY2018Jun 30, 201848.7%+0.9
Q1 FY2018Mar 31, 201849.6%−3.4
Q4 FY2017Dec 31, 201750.9%+5.1
Q3 FY2017Sep 30, 201750.8%+4.0
Q2 FY2017Jun 30, 201747.9%–
Q1 FY2017Mar 31, 201753.0%–
Q4 FY2016Dec 31, 201645.8%–
Q3 FY2016Sep 30, 201646.7%–

More Harvard Bioscience figures

See a number that looks wrong?